Pharma company sees €519m profit from drug sale

A Shannon-based pharma firm last year made a profit of €519m from the sale of the intellectual property of its main drug.

New accounts show that UCB Manufacturing Ireland Ltd recorded pre-tax profits of €461.87m that arose chiefly from the sale of the intellectual property of its Parkinson’s disease drug, Neupro.

Neupro is a skin patch which provides continuous drug delivery for the treatment of every stage of Parkinson’s.